02/17/2020
11:15 PM | Avadel Pharmaceuticals (Filer)
| Form EFFECT
| |
02/14/2020
12:48 PM | Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A
| |
02/13/2020
4:26 PM | Avadel Pharmaceuticals (Subject)
Broadfin Capital, LLC (Filed by)
| Form SC 13G/A
| |
02/13/2020
11:38 AM | Avadel Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
02/05/2020
6:19 AM | Avadel Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/10/2020
4:21 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2020
1:10 PM | Avadel Pharmaceuticals (Subject)
BRANDES INVESTMENT PARTNERS, LP (Filed by)
| Form SC 13G/A
| |
12/30/2019
2:46 PM | Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G
| |
12/17/2019
7:06 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2019
3:21 PM | Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
7:07 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2019
7:10 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2019
8:24 PM | Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
8:21 PM | Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/05/2019
3:30 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2019
3:29 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2019
10:46 AM | Avadel Pharmaceuticals (Subject)
BRANDES INVESTMENT PARTNERS, LP (Filed by)
| Form SC 13G/A
| |
12/05/2019
9:41 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2019
5:22 PM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2019
5:20 PM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/02/2019
8:18 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2019
7:15 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2019
4:10 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
4:03 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
4:00 PM | Avadel Pharmaceuticals (Issuer)
DIVIS GREG J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:46 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2019
4:11 PM | Avadel Pharmaceuticals (Issuer)
Vaughn Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
2:59 PM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
7:01 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2019
3:18 PM | Avadel Pharmaceuticals (Subject)
Broadfin Capital, LLC (Filed by)
| Form SC 13D/A
| |
10/04/2019
3:13 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2019
4:26 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2019
10:31 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2019
7:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2019
7:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
4:05 PM | Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
4:02 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
4:00 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
3:58 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
3:07 PM | Avadel Pharmaceuticals (Issuer)
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
12:07 PM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
7:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
7:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
3:28 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2019
3:06 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2019
3:05 PM | Avadel Pharmaceuticals (Issuer)
GUSKY DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:26 PM | Avadel Pharmaceuticals (Filer)
| Form DEFA14A
| |
06/13/2019
3:22 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2019
3:25 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2019
4:39 PM | Avadel Pharmaceuticals (Issuer)
DIVIS GREG J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
4:10 PM | Avadel Pharmaceuticals (Filer)
| Form DEFR14A
| |
05/24/2019
3:08 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
4:00 PM | Avadel Pharmaceuticals (Filer)
| Form DEFR14A
| |
05/10/2019
3:46 PM | Avadel Pharmaceuticals (Issuer)
STAPLETON CRAIG R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
3:33 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2019
3:59 PM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019
3:11 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
4:51 PM | Avadel Pharmaceuticals (Issuer)
DUBOW JORDAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2019
4:42 PM | Avadel Pharmaceuticals (Issuer)
DUBOW JORDAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2019
3:29 PM | Avadel Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/30/2019
3:03 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2019
12:24 PM | Avadel Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2019
6:16 PM | Avadel Pharmaceuticals (Issuer)
THOMPSON PHILLANDAS T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2019
6:10 PM | Avadel Pharmaceuticals (Issuer)
KANAN MICHAEL F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2019
6:07 PM | Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2019
6:04 PM | Avadel Pharmaceuticals (Issuer)
DIVIS GREG J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2019
3:14 PM | Avadel Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
02/12/2019
5:01 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2019
3:00 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2019
7:55 PM | Avadel Pharmaceuticals (Issuer)
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2019
7:49 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
3:09 PM | ANDERSON MICHAEL S (Reporting)
Avadel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2019
11:54 AM | Avadel Pharmaceuticals (Subject)
BRANDES INVESTMENT PARTNERS, LP (Filed by)
| Form SC 13G/A
| |
12/18/2018
3:06 PM | Avadel Pharmaceuticals (Issuer)
KANAN MICHAEL F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
3:04 PM | Avadel Pharmaceuticals (Issuer)
GUSKY DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
3:01 PM | Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
3:03 PM | Avadel Pharmaceuticals (Issuer)
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2018
4:00 PM | Avadel Pharmaceuticals (Subject)
Broadfin Capital, LLC (Filed by)
| Form SC 13D
| |
12/11/2018
7:59 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2018
9:10 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2018
3:48 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2018
4:03 PM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2018
8:04 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2018
10:13 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2018
7:01 PM | ANDERSON MICHAEL S (Reporting)
Avadel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2018
7:00 PM | Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2018
4:08 PM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2018
8:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2018
3:21 PM | Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2018
3:19 PM | Avadel Pharmaceuticals (Issuer)
STAPLETON CRAIG R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2018
3:17 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2018
3:15 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2018
3:30 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/27/2018
3:27 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/20/2018
3:11 PM | Avadel Pharmaceuticals (Issuer)
VAN ASSCHE BENOIT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2018
3:08 PM | Avadel Pharmaceuticals (Issuer)
NAVARRE CHRISTOPHE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2018
3:07 PM | Avadel Pharmaceuticals (Issuer)
FILDES FRANCIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2018
3:14 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2018
4:38 PM | Avadel Pharmaceuticals (Issuer)
VAN ASSCHE BENOIT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2018
4:35 PM | Avadel Pharmaceuticals (Issuer)
STAPLETON CRAIG R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
